Chronic Malignancies Working Party (CMWP)
Study type:
Study number:
2005-001628-35
Type of Stem Cell Treatment:
Diseases:
Multiple Myeloma (MM) or other Plasma Cell Disorder (PCD)
Short title:
MMVAR
Primary objective:
the hypothesis that treatment with Velcade plus Thalidomide plus Dexamethasone in combination, will result in a longer time progrethe hypothesis that treatment with Velcade plus Thalidomide plus Dexamethasone in combination, will result in a longer time progression than Thalidomide plus Dexamethasone in subjects with relapsed or progressive myeloma after autologous transplanatation.
Key inclusion criteria:
>=18 years old
Country:
France
Belgium
Germany
Switzerland
Austria
Italy
Czech Republic
Hungary
Israel
United Kingdom
Principal investigator:
Laurent Garderet
EBMT Study coordinator:
Marleen van Os